Viewing Study NCT07135050


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-02-05 @ 2:16 PM
Study NCT ID: NCT07135050
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-08-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome
Sponsor: Mahzi Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pitt Hopkins Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MZ-1866 View
None AAV9 Gene Therapy View
None Gene Therapy View
None ICV View
None Intracerebroventricular View
None TCF4 View
None PTHS View